Strategic focus on India aims to make the Swoop® portable MR brain imaging system commercially available in a vast and underserved MRI market
Investing in Malaysia's largest clinic operator to expand the healthcare business
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
Five batches across four programs of Biocon Academy participated in the graduation ceremony
10+ emerging markets, Japan & ANZ transition in final phase
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
The company had submitted a comprehensive Corrective and Preventive Action (CAPA) plan in September 2022
Subscribe To Our Newsletter & Stay Updated
